**Fortune 2024 Ranking: Abbott Laboratories**

At number 108 in the Fortune 2024 rankings, Abbott Laboratories (ABT) is a prominent player in the Health Care sector, specifically operating within the Medical Products and Equipment industry. As a profitable company, Abbott Laboratories has demonstrated its ability to maintain stability and generate revenue despite fluctuations in the market.

Founded in 1888, the company has a rich history, but its current CEO, Robert B. Ford, is not the founder. Despite this, Ford has played a crucial role in shaping the company's direction and navigating its position in the industry. Notably, the company's leadership does not feature a female CEO at the helm.

In terms of employment, Abbott Laboratories boasts a substantial workforce of 114,000 employees worldwide. However, the company did not experience growth in jobs, indicating a possible stabilization or restructuring of its workforce.

The company's ranking in the Fortune 2024 list reflects a decline of 9 positions compared to the previous year, indicating a decrease in its overall performance. This drop in rank is a notable shift, as Abbott Laboratories had previously demonstrated a strong presence in the rankings.

Despite this decline, Abbott Laboratories remains a significant player in the global market, with a presence in the Global 500 and recognition as one of the World's Most Admired Companies. However, it did not make the list of Best Companies to Work For, highlighting an area for potential improvement.

In terms of financial performance, Abbott Laboratories reported revenues of $40,109 million, representing an 8.1% decline from the previous year. The company's profits also decreased by 17.5% to $5,723 million. These declines are notable, but the company's total assets of $73,214 million indicate a strong foundation for future growth.

As a publicly traded company, Abbott Laboratories is listed on the stock exchange and is subject to market fluctuations. Its market value as of March 28, 2024, was $197,221 million, but this had decreased to $179,113 million by July 15, 2024, as indicated in the updated market value.

Headquartered in Abbott Park, Illinois, the company operates under the leadership of Robert B. Ford, with a strong presence in the United States. For more information, investors and stakeholders can visit the company's website at https://www.abbott.com.

In conclusion, Abbott Laboratories remains a significant player in the Health Care sector, despite experiencing a decline in ranking and revenue. As the company navigates the complexities of the medical products and equipment industry, it will be important to monitor its performance and adapt to changing market conditions.